FOXM1 and central nervous system neoplasm: An immunohistochemistry staining confirmed increased levels of FOXM1 expression in MB tumors in comparison to cerebellar control (biopsy specimens of a 6-year-old and a 46-year-old patient without CNS tumor) (Fig. 2c, d).